Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal

JULY 5, 2016

Pharmatest Services Ltd attends Tumor Models 2016 Event in Boston

Pharmatest Services Ltd attends 4th Annual Tumor Models conference in Boston, MA, on July 19 – 21. Pharmatest is sponsoring the conference and holds a scientific oral presentation and poster presentation in the event. The oral presentation is taking place in the afternoon of July 21.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. The Tumor models event organized by Hanson Wade in Boston focuses on effective translation of preclinical knowledge of immunotherapies and combination therapies into clinical utility.

Pharmatest has a booth and the following scientific presentations in the event:

- Oral presentation by Dr. Jenni Bernoulli, the COO of Pharmatest on July 21 at 12.30 pm titled “Why and how to test drug efficacy in mouse models of bone metastasis”.

- Poster presentation starting in the afternoon of July 20 titled "Presence of Immune Infiltrates in Early Phases of Prostate Cancer: Establishment of a Preclinical Efficacy Model to Promote Immunotherapy Development"

Handout of the poster presentation will be available in a link above after the start of the poster session.

If you would like to schedule a meeting with our representatives during the conference, click here.